Adolor Corporation - ADLR- Profile

Adolor Corporation. The Group's principal activity is to discover, develop and market proprietary pharmaceutical products for the treatment of pain and the side effects that are caused by current pain treatments. It's most advanced product candidate, Entereg(R) is intended to block the unwanted effects of analgesics on the gastrointestinal tract. The Group is in the development stage and has a portfolio of small molecule product candidates that are in various stages of development ranging from pre-clinical studies to advanced stage clinical trials. Its product candidate Entereg (R) is designed to selectively block the effects of narcotic analgesics on the gastrointestinal tract. It has collaboration with GlaxoSmithKline for the global development and commercialization of Entereg (R) in multiple indications. Discovers, develops & markets pharmaceutical prods for the treatment of pain & side effects of currently using pain killers